Meihua Bio's 2026 H1 Revenue RMB 12.235 Billion, Net Profit Down 62.56%
Meihua Bio reported 2026 first-half revenue of RMB 12.235 billion, down 0.37% year on year, while net profit attributable to shareholders fell 62.56% to RMB 662 million. Basic earnings per share were RMB 0.24. The company attributed the profit decline to lower prices of major products.
Meihua Bio disclosed its 2026 semi-annual report. During the reporting period, the company achieved operating revenue of RMB 12.235 billion, down 0.37% year on year; net profit attributable to shareholders of the listed company was RMB 662 million, down 62.56% year on year; basic earnings per share were RMB 0.24.
The company stated that during the reporting period, affected by lower prices of major products, overall operating profit declined year on year.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is negative for Condiments, with intensity 60/100 and 70% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.